Avotres is a biotechnology company that provides therapeutic solutions for immunologically mediated disorders.
Avotres has raised $4.0M in total funding. The most recent round was Debt Financing. The last funding was announced in May 2023.
Avotres's investors include Prox Ventures.
Avotres is headquartered in Cedar Knolls, United States.
Avotres is a biotechnology company that provides therapeutic solutions for immunologically mediated disorders.
Avotres is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Avotres — Funding & Investors." VCBacked, May 4, 2023, https://www.vcbacked.co/company/avotres. Accessed August 14, 2026.
VCBacked. (2023). Avotres — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/avotres
{{cite web |title=Avotres — Funding & Investors |url=https://www.vcbacked.co/company/avotres |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated